Skip to main content
Clinical Trials/NCT03240796
NCT03240796UnknownNot Applicable

Secondary Intraocular Lens Implantation in Pediatric Patients: Minimal Invasive Surgery vs. Traditional Cataract Surgery for Treating Congenital Cataracts

Sun Yat-sen University1 site in 1 country80 target enrollmentStarted: August 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
Best corrected visual acuity

Study Overview

Brief Summary

This prospective, non-randomized controlled study aiming at comparing the prognosis of minimal invasive lens surgery and traditional cataract surgery for treating congenital cataracts after the patient receives secondary intraocular artificial lens (IOL) implantation.

Detailed Description

Pediatric patients received minimal invasive surgery and traditional lens removal surgery (anterior capsulorhexis and irrigation/aspiration and posterior capsulorhexis and anterior vitrectomy) are enrolled. The patients are assigned to two groups according to the strategy of primary surgery: Group I: the participants received minimal invasive surgery, while in Group II, the participants received a traditional cataract surgery. Investigators perform a secondary intraocular lens implantation for the patients. Investigators compare the visual acuity, incidence of high intraocular pressure, incidence of visual axis opacification, uveitis and iris/pupil abnormality between two groups after the first and the second surgery, aiming at comparing the prognosis of minimal invasive lens surgery and traditional cataract surgery for treating congenital cataracts.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
24 Months to 72 Months (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age between 24 months and 72 months Uncomplicated congenital cataract and underwent cataract removal Informed consent signed by a parent or legal guardian

Exclusion Criteria

  • Intraocular pressure >21 mmHg at enrollment Preterm birth (<28 weeks) Presence of other ocular diseases (keratitis, keratoleukoma, aniridia, glaucoma) or systemic disease (congenital heart disease, ischemic encephalopathy) History of ocular diseases (any congenital eye diseases, such as, congenital cataract, congenital glaucoma, congenital aniridia) in the family History of ocular trauma Microcornea Persistent hyperplastic primary vitreous Rubella Lowe syndrome

Arms & Interventions

minimal invasive surgery and secondary IOL implantation

Experimental

Intervention: minimal invasive surgery and secondary IOL implantation (Procedure)

traditional cataract surgery and secondary IOL implantation

Active Comparator

Intervention: traditional cataract surgery and secondary IOL implantation (Procedure)

Outcomes

Primary Outcomes

Best corrected visual acuity

Time Frame: recorded at each follow-up (one week, one month, three months, six months after surgery, and every six months thereafter)

measured using the Teller's acuity card, the Lea symbol visual acuity chart or the ETDRS chart according to the patient's age.

Secondary Outcomes

  • Visual axis opacification(recorded at each follow-up (one week, one month, three months, six months after surgery, and every six months thereafter))
  • High intraocular pressure(recorded at each follow-up (one week, one month, three months, six months after surgery, and every six months thereafter))
  • Bi-ocular visual function(The examination is performed when the patient is four years old and older, once a year.)

Investigators

Sponsor
Sun Yat-sen University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Haotian Lin

Clinical Professor

Sun Yat-sen University

Study Sites (1)

Loading locations...

Similar Trials

Secondary Intraocular Lens Implantation in... | Clinical Trial